BMS-986528
/ BMS
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
August 25, 2026
A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
(clinicaltrials.gov)
- P1/2 | N=84 | Recruiting | Sponsor: Bristol-Myers Squibb | Not yet recruiting ➔ Recruiting
Enrollment open • First-in-human • Immunology • Inflammatory Arthritis • Rheumatoid Arthritis • Rheumatology
July 18, 2026
A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
(clinicaltrials.gov)
- P1/2 | N=84 | Not yet recruiting | Sponsor: Bristol-Myers Squibb | Initiation date: May 2026 ➔ Sep 2026
First-in-human • Trial initiation date • Immunology • Inflammatory Arthritis • Rheumatoid Arthritis • Rheumatology
1 to 2
Of
2
Go to page
1